Why the study?
Hypertrophic cardiomyopathy is a heterogeneous myocardial disease often caused by sarcomeric gene mutations, with MYH7 being one of the most common.
Population
Peripheral blood mononuclear cells from one female HCM patient with MYH7 p. R719Q mutation
Design
In vitro stem cell line generation study
Authors
Loading...
May enable patient-specific HCM modeling; leaves open clinical translation of iPSC findings.
The successful generation of this MYH7-mutant iPSC line provides a valuable in vitro model for studying the molecular mechanisms of hypertrophic cardiomyopathy.
Li et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: